Prevalence of depressive symptoms and diagnosed depression among subjects with longstanding type 1 diabetes and no serious chronic complications, hospitalized due to inadequate metabolic control of diabetes
Abstract
Introduction. Depressive symptoms and depressive disorders are common comorbid problems in diabetes. Type 1 diabetes is a chronic disease requiring continuous insulin treatment. A demand for performing daily self-management tasks like blood glucose checks, insulin injections, following healthy diet and maintaining regular physical activity may result in diabetes-related distress and depression. That in turn may be a barrier in achieving therapeutic goals. The aim of this study was to assess the prevalence of depressive symptoms and diagnosed depressive disorder among subjects with long duration of type 1 diabetes and no chronic complications causing disability.
Material and methods. 283 subjects (151 women), aged 43.0 ± 10.7 years, type 1 diabetes duration 27.2 ± 6.1, HbA1c 8.1 ± 1.4% (65 ± 8.2 mmol/mol) were included. Subjects diagnosed with chronic complications causing disability were excluded to avoid the presumable impact of irreversible disability condition on questionnaire answers. Participants were asked to complete the Beck Depression Inventory (BDI) to assess the incidence and intensity of depressive symptoms. The frequency of diagnosed depression disorder was assessed based on the patients’ medical history and medical charts’ review.
Results. 42.0% of subjects exhibited any of depressive symptoms, women two times more frequently. 10.9% of patients had been diagnosed with depressive disorder previously. Among 45 subjects with moderate or severe depressive symptoms, only 17 had been diagnosed with depressive disorder.
Conclusions. Depressive symptoms constitute a serious problem in chronic disease. The results of our study confirm the high prevalence of depressive symptoms among subjects with longstanding type 1 diabetes, although not frequently diagnosed.
Keywords: type 1 diabetesdepressiondepressive symptomsBeck Depression Inventorychronic disease
References
- Gendelman N, Snell-Bergeon JK, McFann K, et al. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care. 2009; 32(4): 575–579.
- Ali S, Stone MA, Peters JL, et al. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006; 23(11): 1165–1173.
- Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010; 87(3): 302–312.
- Herman WH, Kalyani RR, Wexler DJ, et al. American Diabetes Association, American Diabetes Association. Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers. Clin Diabetes. 2016; 34(1): 3–21.
- Nathan DM, Genuth S, Lachin J, et al. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14): 977–986.
- Dziemidok P, Makara-Studzińska M, Jarosz MJ. Diabetes and depression: a combination of civilization and life-style diseases is more than simple problem adding - literature review. Ann Agric Environ Med. 2011; 18(2): 318–322.
- Warren RE, Deary IJ, Frier BM. The symptoms of hyperglycaemia in people with insulin-treated diabetes: classification using principal components analysis. Diabetes Metab Res Rev. 2003; 19(5): 408–414.
- Chan O, Inouye K, Riddell MC, et al. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol. 2003; 28: 87–102.
- Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27(1): 24–31.
- Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009; 26(2): 153–161.
- Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995; 18(6): 754–760.
- Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res. 2003; 12(1): 3–21.
- Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, et al. Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010; 27(2): 217–224.
- Champaneri S, Wand GS, Malhotra SS, et al. Biological basis of depression in adults with diabetes. Curr Diab Rep. 2010; 10(6): 396–405.
- Lyoo InK, Yoon SJ, Musen G, et al. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry. 2009; 66(8): 878–887.
- Holt RIG, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014; 14(6): 491.
- Katon WJ, Simon G, Russo J, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. 2004; 42(12): 1222–1229.
- Li C, Ford ES, Zhao G, et al. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006. Diabetes Res Clin Pract. 2009; 83(2): 268–279.
- Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med. 2006; 23(4): 445–448.
- Oquendo MA, Turret J, Grunebaum MF, et al. Sex differences in clinical predictors of depression: a prospective study. J Affect Disord. 2013; 150(3): 1179–1183.
- Naninck EFG, Lucassen PJ, Bakker J. Sex differences in adolescent depression: do sex hormones determine vulnerability? J Neuroendocrinol. 2011; 23(5): 383–392.